# PVP-Guided Decongestive Therapy in HF

Study · id `cardio:ct-nct05217342` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05217342](<https://clinicaltrials.gov/study/NCT05217342>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05217342

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 586 participants.

## Technical summary

Registry record NCT05217342. Randomized; no masking; primary purpose treatment. Start 2022-01-01 (actual); primary completion 2024-01-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 586 participants (planned count; ClinicalTrials.gov record NCT05217342, source copy `cardio:ctgov-nct05217342-2023-03-14`, retrieved 2026-10-26)
- Started: 2022-01-01 (actual) (ClinicalTrials.gov record NCT05217342, source copy `cardio:ctgov-nct05217342-2023-03-14`, retrieved 2026-10-26)
- Primary completion: 2024-01-01 (anticipated) (ClinicalTrials.gov record NCT05217342, source copy `cardio:ctgov-nct05217342-2023-03-14`, retrieved 2026-10-26)
- Completion: 2024-01-01 (anticipated) (ClinicalTrials.gov record NCT05217342, source copy `cardio:ctgov-nct05217342-2023-03-14`, retrieved 2026-10-26)
- Countries: Türkiye (ClinicalTrials.gov record NCT05217342, source copy `cardio:ctgov-nct05217342-2023-03-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05217342-2023-03-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: PVP-Guided Decongestive Therapy in HF
- Acronym: PERIPHERAL-HF
- Condition: Heart Failure
- Condition: Edema
- Condition: Volume Overload
- Condition: Heart Failure，Congestive
- Intervention (Drug): Diuretic therapy
- Lead sponsor: Marmara University
- Lead sponsor class: OTHER
- Collaborator: Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
- Collaborator class: OTHER
- Collaborator: Başakşehir Çam & Sakura City Hospital
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: 287e5b746aff368ae30dba853bbbe71731a88c6b3072031797bcfa90c3d02c9c
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
